+86 189 1304 2753 product@eynoslifescience.com

A genome-wide in vivo CRISPR screen in colorectal cancer identifies DNMT3A as the top epigenetic driver.

It acts twice: promoter methylation silences TNFRSF1A/B, and a non-enzymatic function opens cholesterol synthesis through NFYA, producing zymosterol that blocks SREBP2 processing. The CAR-T work in this paper used the Eynos RV02-20 retroviral vector at MOI 5.

Key points

Products used in this work

This page is the English summary. The full bench-level article — reagent volumes, step timings, raw flow plots and the caveats — is published in Chinese: read the full article (Chinese). We publish the English edition of every article; where the full text is not translated yet, the summary above carries the numbers and the conclusion.

Questions about this protocol?

Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.